Introduction: Pancreas adenocarcinoma (PDAC) remains a lethal malignancy with a high‐mortality rate and poor long‐term survival. The management of PDAC has evolved over the years to incorporate multidisciplinary care and numerous treatment modalities.
Part of the book: Challenges in Pancreatic Pathology